A double-blind, randomized, placebo-controlled, safety and pilot dose-response study of LL-37 in hard-to-heal venous leg ulcers

Trial Profile

A double-blind, randomized, placebo-controlled, safety and pilot dose-response study of LL-37 in hard-to-heal venous leg ulcers

Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Oct 2013

At a glance

  • Drugs LL 37 (Primary)
  • Indications Leg ulcer
  • Focus Adverse reactions
  • Sponsors Lipopeptide
  • Most Recent Events

    • 14 Oct 2013 New trial record
    • 10 Oct 2013 Results published in a Pergamum media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top